Market open
Vor Biopharma/$VOR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Vor Biopharma
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
Ticker
$VOR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
168
Website
Vor Biopharma Metrics
BasicAdvanced
$57M
Market cap
-
P/E ratio
-$1.74
EPS
-0.35
Beta
-
Dividend rate
Price and volume
Market cap
$57M
Beta
-0.35
52-week high
$3.14
52-week low
$0.63
Average daily volume
584K
Financial strength
Current ratio
6.54
Quick ratio
6.227
Long term debt to equity
30.289
Total debt to equity
34.482
Management effectiveness
Return on assets (TTM)
-39.74%
Return on equity (TTM)
-78.07%
Valuation
Price to book
0.58
Price to tangible book (TTM)
0.58
Price to free cash flow (TTM)
-0.54
Growth
Earnings per share change (TTM)
-11.23%
3-year earnings per share growth (CAGR)
-26.41%
What the Analysts think about Vor Biopharma
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Vor Biopharma stock.
Vor Biopharma Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Vor Biopharma Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Vor Biopharma News
AllArticlesVideos
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
GlobeNewsWire·1 month ago
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
Benzinga·2 months ago
New Clinical Data Validates Vor Bio's Approach of Using Shielded Transplants to Deliver Targeted Therapies
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Vor Biopharma stock?
Vor Biopharma (VOR) has a market cap of $57M as of November 08, 2024.
What is the P/E ratio for Vor Biopharma stock?
The price to earnings (P/E) ratio for Vor Biopharma (VOR) stock is 0 as of November 08, 2024.
Does Vor Biopharma stock pay dividends?
No, Vor Biopharma (VOR) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next Vor Biopharma dividend payment date?
Vor Biopharma (VOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Vor Biopharma?
Vor Biopharma (VOR) has a beta rating of -0.35. This means that it has an inverse relation to market volatility.